Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Preferred sources of health information in persons with multiple sclerosis: degree of trust and information sought.
Ocrelizumab, a humanized monoclonal antibody against CD20 for inflammatory disorders and B-cell malignancies.
Lithium accelerates functional motor recovery by improving remyelination of regenerating axons following ventral root avulsion and reimplantation.
Comparison of brainstem reflex recordings and evoked potentials with clinical and MRI data to assess brainstem dysfunction in multiple sclerosis: a short-term follow-up.
Spontaneous opticospinal encephalomyelitis in a double-transgenic mouse model of autoimmune T cell/B cell cooperation.
Interaction between adolescent obesity and HLA risk genes in the etiology of multiple sclerosis.
Fatigue in multiple sclerosis: an example of cytokine mediated sickness behaviour?
Mouse models for multiple sclerosis: historical facts and future implications.
Relationships between quantitative spinal cord MRI and retinal layers in multiple sclerosis.
The Prevention of Post-Partum Relapses with Progestin and Estradiol in Multiple Sclerosis (POPART'MUS) trial: rationale, objectives and state of advancement.
Experimental autoimmune encephalomyelitis in the mouse.
Expression of the multiple sclerosis-associated MHC class II Allele HLA-DRB1*1501 is regulated by vitamin D.
Pregnancy and multiple sclerosis (the PRIMS study): clinical predictors of post-partum relapse.
LINGO-1 negatively regulates myelination by oligodendrocytes.
Mycophenolate mofetil in multiple sclerosis.
Andiamo! Moving forward with autologous hematopoietic transplantation for highly active MS
Biogen Idec and Genentech Announce Restructuring of anti-CD20 Collaboration Agreement
A regenerative approach to the treatment of multiple sclerosis.
Autologous hematopoietic stem cell transplantation in multiple sclerosis A phase II trial
Micropillar arrays as a high-throughput screening platform for therapeutics in multiple sclerosis.
Roche and Biogen Idec decide to suspend Ocrelizumab treatment - Rheumatoid Arthritis development programme on hold
Ocrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trial.
Ocrelizumab, a humanized anti-CD20 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: a phase I/II randomized, blinded, placebo-controlled, dose-ranging study.
Myelin oligodendrocyte glycoprotein-specific T and B cells cooperate to induce a Devic-like disease in mice.
Estriol generates tolerogenic dendritic cells in vivo that protect against autoimmunity.
Pages
« first
‹ previous
…
9
10
11
12
13
14
15
16
17
…
next ›
last »